ABP
CELG

Arthur B. Page’s Celgene Corp CELG Stock Holding History

Arthur B. Page’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,385
Closed -$591K – 62
2019
Q2 		$591K Sell
6,385
-2,818
-31% -$268K 0.48% 45
2019
Q1 		$868K Buy
9,203
+10
+0.1% +$875 0.72% 39
2018
Q4 		$590K Sell
9,193
-540
-6% -$39.9K 0.57% 46
2018
Q3 		$870K Buy
9,733
+1,775
+22% +$157K 0.74% 39
2018
Q2 		$633K Buy
7,958
+718
+10% +$59.6K 0.58% 44
2018
Q1 		$645K Buy
+7,240
New +$695K 0.58% 44

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arthur B. Page's CELG Position: Q3 2019 in Review

Arthur B. Page sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 6,385 shares — an estimated $591K sold.

Arthur B. Page first reported a position in CELG in Q1 2018 and held it in 6 quarters. The position peaked at $870K in Q3 2018. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Arthur B. Page reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Arthur B. Page sold 6,385 Celgene Corp shares in Q3 2019, an estimated $591K.
  • Arthur B. Page first reported a position in Celgene Corp in Q1 2018 and held it in 6 quarters.
  • Arthur B. Page's Celgene Corp position peaked at $870K in Q3 2018.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Arthur B. Page's 13F filing for Q3 2019, filed 4 Nov 2019.